
ALL-IN-ONE Relief
Results in all key clinical manifestations of PsA and the hallmarks of disease that matter to patients with nr-axSpA

Featured Content Card
Featured Content Card
Featured Content
ACR20 responses at Week 2 in a mixed population exploratory analysis ↗
Paragraph 1 uncontrolled exploratory analysis ↗: Nonresponder imputation in a subgroup co2 of biologic-naive patients h2O from Week 1 to Week 24. No clinical statistical conclusions can be drawn.4,5
-
31% for 300 mg (n=222) lorem ipsum dolor sit 1 to Week 24.
-
26% for 150 mg (n=220)
-
15% for placebo (n=332)
FUTURE 5 uncontrolled exploratory analysis: Nonresponder imputation in a subgroup of biologic-naive patients from Week 1 to